跳至主要内容
临床试验/NCT04223102
NCT04223102进行中(未招募)不适用

Rectal Microbiome Variability Among Rectal Cancer Cohorts Including Complete Clinical Responders, Pathologic Responders, and Early Recurrence

University of South Florida6 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年2月18日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
40
试验地点
6
主要终点
16s rRNA gene sequencing to study bacterial phylogeny and taxonomy

研究概览

简要总结

The purpose of our study is to determine if an association exists between the microbiome of those with rectal adenocarcinoma who are complete pathologic responders and those who have a partial or no response to neoadjuvant therapy.

详细描述

This study will help to further elucidate the association of bacteria with rectal cancer, while also characterizing the genes associated with that risk. Furthermore it will attempt to better understand which patients may have an optimal response to neoadjuvant chemoradiation allowing for possible predictive metagenomics evaluation, investigators may be able to augment treatments as well as provide recommendations for the success and cost effectiveness of cancer care.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years old
  • Locally Advanced Rectal Adenocarcinoma (T3)
  • Standard 5FU based chemoradiation
  • Total Neoadjuvant Therapy per OPRA protocol guidelines

排除标准

  • Age < 18 years
  • Stage I or Stage IV rectal adenocarcinoma
  • Rectal cancer other than adenocarcinoma
  • Genetically associated cancer (HNPCC, FAP etc.) or highly suspicious for genetically associated cancer
  • Prior history of rectal adenocarcinoma (i.e. recurrent colorectal adenocarcinoma)

结局指标

主要结局

16s rRNA gene sequencing to study bacterial phylogeny and taxonomy

时间窗: 5 years

16s rRNA sequencing from biopsy specimens

次要结局

  • rectal microbiota to study bacteria strains(5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验